- Home
- HON vs FBIOP Comparison
HON vs FBIOP Comparison
Compare HON & FBIOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HON
- FBIOP
- Stock Information
- Founded
- HON 1885
- FBIOP N/A
- Country
- HON United States
- FBIOP United States
- Employees
- HON N/A
- FBIOP 186
- Industry
- HON Aerospace
- FBIOP Biotechnology: Pharmaceutical Preparations
- Sector
- HON Industrials
- FBIOP Health Care
- Exchange
- HON Nasdaq
- FBIOP Nasdaq
- Market Cap
- HON N/A
- FBIOP N/A
- IPO Year
- HON N/A
- FBIOP N/A
- Fundamental
- Price
- HON $229.81
- FBIOP $6.37
- Analyst Decision
- HON Buy
- FBIOP
- Analyst Count
- HON 14
- FBIOP 0
- Target Price
- HON $246.46
- FBIOP N/A
- AVG Volume (30 Days)
- HON 3.8M
- FBIOP N/A
- Earning Date
- HON 01-30-2025
- FBIOP N/A
- Dividend Yield
- HON 1.99%
- FBIOP N/A
- EPS Growth
- HON 7.36
- FBIOP N/A
- EPS
- HON 8.65
- FBIOP N/A
- Revenue
- HON $37,850,000,000.00
- FBIOP N/A
- Revenue This Year
- HON $6.59
- FBIOP N/A
- Revenue Next Year
- HON $7.64
- FBIOP N/A
- P/E Ratio
- HON $26.21
- FBIOP N/A
- Revenue Growth
- HON 3.96
- FBIOP N/A
- 52 Week Low
- HON $189.66
- FBIOP N/A
- 52 Week High
- HON $242.77
- FBIOP N/A
- Technical
- Relative Strength Index (RSI)
- HON 60.74
- FBIOP 51.85
- Support Level
- HON $225.87
- FBIOP $6.40
- Resistance Level
- HON $238.31
- FBIOP $7.10
- Average True Range (ATR)
- HON 4.31
- FBIOP 0.72
- MACD
- HON 0.03
- FBIOP -0.01
- Stochastic Oscillator
- HON 68.94
- FBIOP 50.66
About FBIOP Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology, therapeutics sectors.